REG - Byotrol PLC - Capital Reorganisation Delay

ByotrolAnnouncement

22/04/2024 16:45

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240422:nRSV5690La&default-theme=true

RNS Number : 5690L  Byotrol PLC  22 April 2024

 

 

Byotrol Plc

("Byotrol" or the "Company")

 

Capital Reorganisation Delay

 

Byotrol Plc (AIM: BYOT), the specialist infection prevention and control
company, announces that owing to an administrative error the Company's Capital
Reorganisation as previously announced will no longer become effective at the
close of business today but instead at the close of business on 24 April 2024.

 

The Company confirms that the cancellation of admission of the Company's
ordinary shares to trading on AIM remains effective at 7.00 a.m. on 30 April
2024. The Company will re-register as a private limited company with the name
Byotrol Limited which is expected to take by 21 May 2024.

 

Unless otherwise indicated, defined terms in this announcement shall have the
same meaning as described in the Circular.

 

 

For further information contact:

 

 Byotrol Plc
 Dr Trevor Francis, Non- Executive Chairman                                           +44 (0)1925 742 000
 David Traynor, Interim Chief Executive Officer

 Chris Sedwell, Chief Financial Officer

 Cavendish Capital Markets Limited (Nominated Adviser and Broker)                     +44 (0)20 7220 0500
 Geoff Nash/George Dollemore - Corporate Finance

 Nigel Birks/Harriet Ward - ECM

 Flagstaff Strategic and Investor Communications                                      +44 (0)20 7129 1474
 Tim Thompson/Andrea Seymour/Fergus Mellon                                            byotrol@flagstaffcomms.com (mailto:byotrol@flagstaffcomms.com)

 

 

 

 

 

Notes to editors

 

Byotrol plc (BYOT.L), quoted on AIM, is a specialist infection prevention and
control company, operating globally in the animal and human healthare,
industrial, institutional and consumer sectors, providing low toxicity
products with a broad-based and targeted efficacy across all microbial
classes; bacteria, viruses (including coronavirus), fungi, moulds,
mycobacteria and algae.

 

Byotrol's products can be used stand-alone or as ingredients within existing
products, where they can significantly improve their performance, especially
in personal hygiene, domestic and industrial disinfection, odour control, food
production and food management.

 

Byotrol develops and commercialises technologies that create easier, safer and
cleaner lives for everyone.

 

For more information, go to byotrol.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  CAREASLAALALEFA